Pediatrix Medical
223 hedge funds and large institutions have $777M invested in Pediatrix Medical in 2023 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 90 increasing their positions, 64 reducing their positions, and 17 closing their positions.
867% more call options, than puts
Call options by funds: $261K | Put options by funds: $27K
112% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 17
41% more repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 64
9% more funds holding
Funds holding: 205 → 223 (+18)
1.72% more ownership
Funds ownership: 97.74% → 99.46% (+1.7%)
25% less capital invested
Capital invested by funds: $1.04B → $777M (-$265M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$20.4M |
| 2 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$18.7M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$16M |
| 4 |
Boston Partners
Boston,
Massachusetts
|
+$13.8M |
| 5 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$6.88M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lazard Asset Management
New York
|
-$84.9M |
| 2 |
RRAM
River Road Asset Management
Louisville,
Kentucky
|
-$12.3M |
| 3 |
PCM
Palisade Capital Management
Fort Lee,
New Jersey
|
-$10.5M |
| 4 |
Goldman Sachs
New York
|
-$4.35M |
| 5 |
EARNEST Partners
Atlanta,
Georgia
|
-$2.93M |
MD Hedge Fund Activity: Q4 2023 in Review
223 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q4 2023, worth a combined $777M — down 25% from $1.04B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new MD positions and 17 closed out — a net gain of 19 holders — while 90 added to existing stakes and 64 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $20.4M. The largest seller was Lazard Asset Management, cutting an estimated $84.9M.
- 223 institutional investors held Pediatrix Medical (MD) as of Q4 2023, up from 205 in Q3 2023.
- Funds reported $777M of Pediatrix Medical stock for Q4 2023, down 25% quarter-over-quarter.
- 36 funds opened new Pediatrix Medical positions in Q4 2023 and 17 closed out, a net change of +19 holders.
- The largest Pediatrix Medical buyer in Q4 2023 was Morgan Stanley, an estimated $20.4M added.
- The largest Pediatrix Medical seller in Q4 2023 was Lazard Asset Management, an estimated $84.9M sold.
Based on aggregated 13F filings for Q4 2023.